Angiotensin II Signaling Through A Novel NF-kB Pathway
Angiotensin II Signaling Through A Novel NF-kB Pathway
批准号:
7555362
负责人:
PETER C LUCAS
金额:
$35.28万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2013-01-31
关键词:
Adrenal GlandsAdverse effectsAldosteroneAngiotensin IIAngiotensin II ReceptorAntigen ReceptorsArteriesAtherosclerosisB-LymphocytesBiochemicalBlood PressureBlood VesselsCardiovascular DiseasesCardiovascular PathologyCardiovascular systemCell membraneCellsChronicComplexCoronary arteryCoupledDataDevelopmentDrug or chemical Tissue DistributionEventExposure toFunctional disorderG-Protein-Coupled ReceptorsGrowth FactorHeart HypertrophyHormonesHypertensionInflammation MediatorsInflammatoryInflammatory ResponseInterventionKidneyKnockout MiceKnowledgeLeadLigandsLigationLinkLymphocyteMediatingMolecularMuscleMuscle TensionNF-kappa BPathologicPathway interactionsPharmacologic SubstancePhospholipase CPhosphotransferasesPhysiologicalProtein IsoformsProtein Kinase CProteinsReceptor ActivationReceptor SignalingRoleScaffolding ProteinSignal PathwaySignal TransductionSignaling ProteinSmooth MuscleSmooth Muscle MyocytesSodiumStimulusTestingTissuesUbiquitinWaterblood pressure regulationcitrate carriercytokinedesignimmune functionlink proteinmacrophagemembernovelpeptide hormoneprotein complexreceptorreceptor bindingresponsetranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Angiotensin II (Ang II) has recently become recognized as a powerful pro-inflammatory mediator. Although originally appreciated for its critical role in regulating blood pressure, this peptide hormone is now known to stimulate inflammatory pathways in numerous tissues, including the heart and arteries. Chronic exposure to Ang II may then lead to a variety of pathologic conditions related to a heightened inflammatory state. Perhaps the best example is in muscular arteries, where Ang II contributes to the development of atherosclerosis by stimulating the recruitment of macrophages and other inflammatory cells, stimulating smooth muscle proliferation and activation, and promoting endothelial dysfunction. The principal receptor for Ang II (AT1R) is a member of the G protein-coupled receptor superfamily. Numerous signaling pathways are initiated following ligand activation of this receptor, but stimulation of the NF-:B transcription factor appears to underlie most of the pro-inflammatory effects of Ang II. Importantly, while activation of protein kinase C (PKC) is a prerequisite for this effect, very little is known about the intermediate steps that bridge Ang II-dependent PKC activation with the eventual stimulation of NF-:B. However, our preliminary data now reveal a molecular link to explain this phenomenon. Our data indicate that a scaffolding protein (CARMA3) serves to integrate an upstream signal from PKC with the downstream effector proteins, Bcl10 and MALT1, which together stimulate a canonical pathway for NF-:B activation. We propose to explore the physiologic and biochemical implications of this signaling pathway through 4 aims: (1) Identify the molecular mechanism by which the AT1 receptor communicates with CARMA3. (2) Identify the molecular mechanism by which the IKK complex is activated following Ang II stimulation. (3) Test the role of CARMA3, Bcl10, and MALT1 in mediating Ang II-dependent inflammatory responses in endothelial and vascular smooth muscle cells. (4) Test the role of CARMA3 in mediating Ang II-dependent cardiovascular pathology, through analysis of CARMA3 knockout mice.
Project Relevance: Ang II-dependent hypertension is a major contributing factor to cardiovascular disease. Understanding the pro-inflammatory, intracellular signaling events activated by Ang II is critical for our ability to eventually control the adverse effects of Ang II. Detailed knowledge of these signaling events will allow for the rational design of pharmacologic agents to target these events.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of MALT1 in regulating the breast cancer immune microenvironment
-
批准号:10656975
-
项目类别:
-
资助金额:$52.67万
-
财政年份:2023
-
负责人:PETER C LUCAS
-
依托单位:
New mechanisms for modulating the MALT1 oncoprotein
-
批准号:10092117
-
项目类别:
-
资助金额:$37.61万
-
财政年份:2018
-
负责人:PETER C LUCAS
-
依托单位:
New mechanisms for modulating the MALT1 oncoprotein
-
批准号:9445635
-
项目类别:
-
资助金额:$53.69万
-
财政年份:2018
-
负责人:PETER C LUCAS
-
依托单位:
Novel signal pathway mediating Hypertension/Obesity-dependent Insulin Resistance
-
批准号:8305801
-
项目类别:
-
资助金额:$6.91万
-
财政年份:2009
-
负责人:PETER C LUCAS
-
依托单位:
A Novel Signaling Pathway Mediating Hypertension- and Obesity-dependent Insulin R
-
批准号:7649758
-
项目类别:
-
资助金额:$35.14万
-
财政年份:2009
-
负责人:PETER C LUCAS
-
依托单位:
Novel signal pathway mediating Hypertension/Obesity-dependent Insulin Resistance
-
批准号:8081071
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2009
-
负责人:PETER C LUCAS
-
依托单位:
Novel signal pathway mediating Hypertension/Obesity-dependent Insulin Resistance
-
批准号:8611325
-
项目类别:
-
资助金额:$23.99万
-
财政年份:2009
-
负责人:PETER C LUCAS
-
依托单位:
A Novel Signaling Pathway Mediating Hypertension- and Obesity-dependent Insulin R
-
批准号:7846142
-
项目类别:
-
资助金额:$34.79万
-
财政年份:2009
-
负责人:PETER C LUCAS
-
依托单位:
Novel signal pathway mediating Hypertension/Obesity-dependent Insulin Resistance
-
批准号:8478086
-
项目类别:
-
资助金额:$30.75万
-
财政年份:2009
-
负责人:PETER C LUCAS
-
依托单位:
Angiotensin II Signaling Through A Novel NF-kB Pathway
-
批准号:7780019
-
项目类别:
-
资助金额:$35.28万
-
财政年份:2008
-
负责人:PETER C LUCAS
-
依托单位:
Angiotensin II Signaling Through A Novel NF-kB Pathway
-
批准号:8220814
-
项目类别:
-
资助金额:$20.33万
-
财政年份:2008
-
负责人:PETER C LUCAS
-
依托单位:
GPCR Signaling Through a Novel NF-kB Pathway
-
批准号:9211376
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:PETER C LUCAS
-
依托单位:
GPCR Signaling Through a Novel NF-kB Pathway
-
批准号:8991501
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:PETER C LUCAS
-
依托单位:
Angiotensin II Signaling Through A Novel NF-kB Pathway
-
批准号:8597477
-
项目类别:
-
资助金额:$14.6万
-
财政年份:2008
-
负责人:PETER C LUCAS
-
依托单位:
GPCR Signaling Through a Novel NF-kB Pathway
-
批准号:8607204
-
项目类别:
-
资助金额:$36.56万
-
财政年份:2008
-
负责人:PETER C LUCAS
-
依托单位:
GPCR Signaling Through a Novel NF-kB Pathway
-
批准号:8437612
-
项目类别:
-
资助金额:$38.13万
-
财政年份:2008
-
负责人:PETER C LUCAS
-
依托单位:
Angiotensin II Signaling Through A Novel NF-kB Pathway
-
批准号:7367945
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2008
-
负责人:PETER C LUCAS
-
依托单位:
NF-kB Signaling & Molec Pathogenesis of MALT Lymphoma
-
批准号:7086322
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2002
-
负责人:PETER C LUCAS
-
依托单位:
NF-kB Signaling & Molec Pathogenesis of MALT Lymphoma
-
批准号:6917846
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2002
-
负责人:PETER C LUCAS
-
依托单位:
NF-kB Signaling & Molec Pathogenesis of MALT Lymphoma
-
批准号:6459446
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2002
-
负责人:PETER C LUCAS
-
依托单位:
海外基金